See today's BioWorld Science
To read the full story, subscribe or sign in.
Ear, nose & throat

Ribox’s RXRG-001 cleared to enter clinic for radiation-induced xerostomia and hyposalivation

Oct. 28, 2024
Ribox Therapeutics Ltd. has obtained IND clearance from the FDA for the company’s circular RNA therapy, RXRG-001.
BioWorld Science Regulatory Cancer Ear, nose and throat FDA IND